drugset / Trial / NCT00417326
Controlled Study of ONO-5046Na in Patients With Acute Respiratory Failure Associated With Community-Acquired Pneumonia
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine the safety and efficacy of ONO-5046Na in patients with acute respiratory failure associated with community-acquired pneumonia
Timeline
- Start
- 2006-12
- Primary completion
- 2009-08
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sivelestat | Small molecule | 0 mg/kg | Intravenous |
| Subject | Sivelestat | Small molecule | 0.2 mg/kg | Intravenous |